Trastuzumab deruxtecan for Named Patient Import

Trastuzumab deruxtecan for Indian Patients

Trastuzumab deruxtecan is a newly introduced FDA medication. It is an anti-cancer drug approved for breast cancer and gastric cancer treatments. It is a product of AstraZeneca which is known for developing several advanced innovative drugs for cancer management. Trastuzumab deruxtecan is registered as Enhertu, the brand name slowly gaining more prominence. This medication is available in the US and European markets. Enhertu 100 mg vial is the available commercial pack. Trastuzumab deruxtecan or Enhertu in India is not readily available. Enhertu 100 mg in India will be officially launched after its country specific registration. But, FDA and EMA approvals are often used as basis by Indian Oncologists for prescribing advanced medicines. Enhertu (Trastuzumab deruxtecan) price in India is determined based on the prevailing global scenario. Legally sourcing medications like this is always safe and reliable in order to retain their desired quality.

Trastuzumab deruxtecan in India? Seek professional assistance

We have been finetuning our services to proactively assist patients in India who seek the access for advanced medications. Trastuzumab deruxtecan India sourcing channels will be helpful when you look for cost and other relevant details. These are verified and trusted global sources. When you engage experienced professionals trusted for on time delivery, you can conveniently plan your schedules. If quality services and timely assistance is what you are looking for, our team is the right fit for you.

You can write to us or call us - nhs@noelbiotech.com; + 91 9677010046 / + 91 9929277766.